Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Herpetic eye disease.

D J Coster, R D Grutzmacher

    Australian Journal of Ophthalmology
    |February 1, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Herpetic keratitis, a viral eye infection, involves epithelial and stromal disease. Treatment strategies differ, focusing on antiviral replication for epithelial issues and anti-inflammation for stromal complications.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The influence of rejection episodes in recipients of bilateral corneal grafts.

    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2010
    Same author

    A steroid-inducible promoter for the cornea.

    The British journal of ophthalmology·2009
    Same author

    Mechanisms of corneal allograft rejection and regional immunosuppression.

    Eye (London, England)·2009
    Same author

    Antibody-based immunosuppressive agents for corneal transplantation.

    Eye (London, England)·2009
    Same author

    Prospects for genetic modulation of corneal graft survival.

    Eye (London, England)·2008
    Same author

    Lentivirus-mediated gene transfer to the rat, ovine and human cornea.

    Gene therapy·2007
    Same journal

    The use of extended wear contact lenses in aphakia.

    Australian journal of ophthalmology·1984
    Same journal

    Closed microsurgery in trauma.

    Australian journal of ophthalmology·1984
    Same journal

    Fine needle aspiration biopsy of orbital lesions using CT scan control.

    Australian journal of ophthalmology·1984
    Same journal

    Macular electroretinograms: their accuracy, specificity and implementation for clinical use.

    Australian journal of ophthalmology·1984
    Same journal

    Solitary silent venous papillary loops and ocular hypertension.

    Australian journal of ophthalmology·1984
    Same journal

    Repositioning of Descemet's membrane: a case report.

    Australian journal of ophthalmology·1984
    See all related articles

    Area of Science:

    • Ophthalmology
    • Virology
    • Immunology

    Background:

    • Herpetic keratitis is a frequent ocular condition with potential for severe complications.
    • Disease manifestation results from virus-host interactions.
    • Epithelial changes stem from viral cytopathic effects and replication.

    Purpose of the Study:

    • To differentiate treatment approaches for epithelial versus stromal herpetic keratitis.
    • To review the role of antiviral agents in managing herpetic keratitis.
    • To highlight the complexities in treating stromal disease.

    Main Methods:

    • Review of viral cytopathic effects in ocular epithelium.
    • Analysis of inflammatory mechanisms in stromal disease.
    • Evaluation of clinical trial data for antiviral agents.

    Related Experiment Videos

    Main Results:

    • Epithelial disease treatment targets viral replication.
    • Stromal disease treatment aims to suppress inflammation without increasing viral replication.
    • Various antiviral agents exist, each suited for specific clinical scenarios.

    Conclusions:

    • Management of epithelial herpetic keratitis focuses on antiviral therapy.
    • Stromal herpetic keratitis management is complex, requiring anti-inflammatory approaches.
    • Further clinical trial data is needed for optimal stromal disease treatment strategies.